Osmotically stabilized microbubble preparations

• US 7,005,120 B2
• Filed: 02/17/2004
• Issued: 02/28/2006
• Est. Priority Date: 07/30/1993
• Status: Expired due to Fees

• Current Assignee: Targeson, Inc.
• Original Assignee: IMCOR Pharmaceutical Company
• Inventors: Schutt, Ernest G., Weers, Jeffry G., Anderson, Charles David, Kinner, Rene Alta, Evitts, David P.
• Primary Examiner(s): HARTLEY, MICHAEL G
• Application Number:
  US10/780,502
• Publication Number:
  US 20040228801A1
• Time in Patent Office: 742 Days
• Field of Search: 424/9.52, 424/9.51, 424/9.5, 516/11, 516/77
• US Class Current: 424/9.52
• CPC Class Codes: A61K 49/223 Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
• CPC Class Codes: A61K 49/227 Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
• CPC Class Codes: G02B 6/0006 Coupling light into the fibre in general G02B6/4298

Abstract

A microbubble preparation formed of a plurality of microbubbles comprising a first gas and a second gas surrounded by a membrane such as a surfactant, wherein the first gas and the second gas are present in a molar ratio of from about 1:100 to about 1000:1, and wherein the first gas has a vapor pressure of at least about (760-x) mm Hg at 37° C., where x is the vapor pressure of the second gas at 37° C., and wherein the vapor pressure of each of the first and second gases is greater than about 75 mm Hg at 37° C.; also disclosed are methods for preparing microbubble compositions, including compositions that rapidly shrink from a first average diameter to a second average diameter less than about 75% of the first average diameter and are stabilized at the second average diameter; kits for preparing microbubbles; and methods for using such microbubbles as ultrasound contrast agents.

Claims

1. A microbubble for use in diagnostic imaging in a liquid medium wherein the microbubble transports physiological gases in vivo wherein the microbubble comprises a membrane and at least one fluorocarbon gas and at least one modifier gas wherein the microbubble grows and shrinks to maintain osmotic equilibrium with the physiological gas saturation of the surrounding liquid medium.

2. The microbubble of claim 1 wherein the modifier gas saturation level changes in the bubble as the microbubble circulates in the bloodstream of the patient.

3. The microbubble of claim 1 wherein the surrounding liquid medium is blood.

4. The microbubble of claim 1 wherein the modifier gas is at least one gas selected from the group consisting of oxygen, nitrogen and carbon dioxide.

5. The microbubble of claim 1 wherein the microbubble grows when the modifier gas of the microbubble exchanges with gases present in the surrounding liquid medium.

6. The microbubble of claim 5 wherein the gas present in the surrounding liquid medium is oxygen.

7. The microbubble of claim 5 wherein the gas present in the surrounding liquid medium is air.

8. The microbubble of claim 1 wherein the at least one fluorocarbon gas is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, perfluoromethylcyclopentanes, perfluorohexanes, perfluorocyclohexanes, perfluoromethylcyclopentanes, perfluorodimethylcyclobutanes, perfluoroheptanes, perfluorocycloheptanes, perfluoromethylcyclohexanes, perfluorodimethylcyclopentanes, perfluorotrimethylcyclobutanes, and perfluorotriethylamines.

9. A microbubble for use in diagnostic imaging in a liquid medium, wherein the microbubble transports physiological gases and wherein the microbubble comprises at least one fluorocarbon gas and at least one modifier gas comprising oxygen wherein the microbubble grows or-shrinks in the surrounding liquid medium.

10. The microbubble composition of claim 9 wherein the fluorocarbon gas is perfluorohexane.

11. The microbubble of claim 9 wherein the microbubble grows in diameter to maintain osmotic equilibrium of oxygen within the microbubble with the oxygen in the surrounding liquid medium.

12. The microbubble of claim 9 wherein the surrounding liquid medium is blood.

13. The microbubble of claim 9 wherein the first fluorocarbon gas is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, peffluoromethylcyclopentanes, perfluorohexanes, perfluorocyclohexanes, perfluoromethylcyclopentanes, perfluorodimethylcyclobutanes, perfluoroheptanes, perfluorocycloheptanes, perfluoromethylcyclohexanes, perfluorodimethylcyclopentanes, perfluorotrimethylcyclobutanes, and perfluorotriethylamines.

14. The microbubble of claim 9 wherein the microbubble further comprises a membrane.

15. The microbubble of claim 10 wherein the microbubble further comprises a membrane.

16. A microbubble composition for use in diagnostic imaging in a liquid medium wherein the microbubble comprises a membrane and transports physiological gases in vivo wherein the microbubble comprises at least one fluorocarbon gas and at least one modifier gas wherein the microbubble first shrinks as a result of loss of the modifier gas to the surrounding liquid medium and then grows as the microbubble gains osmotic equilibrium with the physiological gas saturation of the surrounding liquid medium.

17. The microbubble composition of claim 16 wherein the modifier gas is selected from the group consisting of oxygen, nitrogen and carbon dioxide.

18. The microbubble composition of claim 16 wherein the transported physiological gas is oxygen.

19. The microbubble composition of claim 16 wherein the fluorocarbon gas is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, perfluoromethylcyclopentanes, perfluorohexanes, perfluorocyclohexanes, perfluoromethylcyclopentanes, perfluorodimethylcyclobutanes, perfluoroheptanes, perfluorocycloheptanes, perfluoromethylcyclohexanes, perfluorodimethylcyclopentanes, perfluorotrimethylcyclobutanes, and verfluorotriethylamines.